HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) sold 1.9% of their position (1.28K shares) of ULTRAGENYX PHARMACEUTICAL INC. on the open market
Open‑market sale worth $17.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2026ACC: 0001193125-26-392233
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-1.28K
Net shares
Net seller
$17.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.28K
Price / share
$13.57
Trade value
$17.41K
% of position
1.9%
9/15/2026
69.15K→67.86K
Total
Net shares
−1.28K
Net value
-$17.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | S · Sale | −1.28K | $13.57 | $17.41K | 1.9% | 69.15K | 67.86K |
| Total | −1.28K | -$17.41K | ||||||
Derivative Transactions0
No derivative transactions reported